Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation

Nephrol Dial Transplant. 2011 Jan;26(1):365-8. doi: 10.1093/ndt/gfq542. Epub 2010 Sep 3.

Abstract

Patients after solid organ transplantation are at increased risk of developing herpes zoster and are more likely to develop major complications such as cutaneous dissemination, post-herpetic neuralgia and visceral organ involvement. We report on a 68-year-old woman being varicella-zoster virus (VZV)-seropositive prior to transplantation, who developed fatal VZV meningoencephalitis after renal transplantation presenting with non-specific neurologic symptoms. The case illustrates that VZV reactivation may occur in renal transplant recipients in the absence of skin lesions. Approaches towards risk assessment pre-transplantation and prophylactic regimens for the prevention of VZV recurrence are needed.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use
  • Female
  • Herpes Zoster / etiology*
  • Herpes Zoster / therapy
  • Herpesvirus 3, Human / pathogenicity*
  • Humans
  • Kidney Transplantation / adverse effects*
  • Meningoencephalitis / etiology*
  • Prognosis
  • Skin Diseases*
  • Virus Activation*

Substances

  • Antiviral Agents